Researchers identified three new all-oral drug regimens that include at least one of two new drugs for treatment of ...

Introduction Globally, tuberculosis (TB) remains one of the leading infectious causes of death, with 1.3 million deaths.

HIV is spread by bodily fluids such as blood, breast milk or semen. It gradually weakens the body's immune system and makes ...

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.

According to the officials, the new regimen, called BPaL/BPaLM, includes medications bedaquiline, pretomanid, linezolid, and ...

A landmark review in Molecular Biomedicine outlines cutting-edge strategies to combat tuberculosis (TB), highlighting novel ...

A study reveals AI's role in identifying antimicrobial compounds for tuberculosis, enhancing drug development through ...

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and into the lungs, the pathogen that causes "TB" can lead to chronic cough, ...

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and ...

and RR (rifampicin-resistant) tuberculosis and should be a focus for case-finding efforts." Rifampicin is a key drug recommended by the World Health Organisation as a first-line treatment for TB.

Resistance to rifampin and multidrug-resistant TB was consistently low (1% to 2% of samples). Extensively drug-resistant TB was rare and only reported in 2014, 2018 and 2021 (1 sample in each year).